08.02.04 |
Formulary
|
 |
Atezolizumab (Tecentriq®) |
08.02.04 |
Formulary
|
 |
Axicabtagene ciloleuce (Yescarta®) |
08.01.05 |
Formulary
|
 |
Brentuximab vedotin Adcetris® |
08.02.04 |
Formulary
|
 |
Glatiramer Acetate Copaxone® |
08.02.04 |
Formulary
|
 |
Immunocellular therapy containing tisagenlecleucel, autologous T cells genetically modified ex vivo using a lentiviral vector encoding an anti-CD19 chimeric antigen receptor (CAR) (Kymriah®) |
08.01 |
Formulary
|
 |
Inotuzumab ozogamicin Besponsa® |
08.02.04 |
Formulary
|
 |
Talimogene laherparepvac Imlygic® |
08.01.05 |
Formulary
|
 |
Trastuzumab emtansine Kadcyla® |
08.01.05 |
Formulary
|
 |
Trifluridine and Tipiracil Lonsurf ® |